The employer needs to be notified that the Comirnaty jab, that is the only one approved by the FDA , is not even available in the US and there is no timetable for when it will be. Although the FDA has stated that the BioNTech jab is interchangeable with Comirnaty, they are treated as two separate entities and are not legally the same jab. The BioNTech jab is still under EUA and is classified as experimental. There are NO FDA approved vaxxines available in the US - PERIOD!
Therefore, all the current vaxxines available in the US are still under EUA only and cannot be mandated. In addition, the liability waiver for those jabs is still in effect and no data is available as to the complete list of ingredients they contain and must still be classified as part of a clinical trial. Complete informed consent is impossible.
Comirnaty has the same formulation as the FDA-authorized Pfizer-BioNTech COVID-19 vaccine and can be used interchangeably to provide the COVID-19 vaccination series without presenting any safety or effectiveness concerns. The products are legally distinct with certain differences that do not impact safety or effectiveness.
The employer needs to be notified that the Comirnaty jab, that is the only one approved by the FDA , is not even available in the US and there is no timetable for when it will be. Although the FDA has stated that the BioNTech jab is interchangeable with Comirnaty, they are treated as two separate entities and are not the same jab. The BioNTech jab is still under EUA and is classified as experimental. There are NO FDA approved vaxxines available in the US - PERIOD!
Therefore, all the current vaxxines available in the US are still under EUA only and cannot be mandated. In addition, the liability waiver for those jabs is still in effect and no data is available as to the complete list of ingredients they contain and must still be classified as part of a clinical trial. Complete informed consent is impossible.
Comirnaty has the same formulation as the FDA-authorized Pfizer-BioNTech COVID-19 vaccine and can be used interchangeably to provide the COVID-19 vaccination series without presenting any safety or effectiveness concerns. The products are legally distinct with certain differences that do not impact safety or effectiveness.
The employer needs to be notified that the Comirnaty jab, that is the only one approved by the FDA , is not even available in the US and there is no timetable available for when it will be. Although the FDA has stated that the BioNTech jab is interchangeable with Comirnaty, they are treated as two separate entities and are not the same jab. The BioNTech jab is still under EUA and is classified as experimental. There are NO FDA approved vaxxines available in the US - PERIOD!
Therefore, all the current vaxxines available in the US are still under EUA only and cannot be mandated. In addition, the liability waiver for those jabs is still in effect and no data is available as to the complete list of ingredients they contain and must still be classified as part of a clinical trial. Complete informed consent is impossible.
Comirnaty has the same formulation as the FDA-authorized Pfizer-BioNTech COVID-19 vaccine and can be used interchangeably to provide the COVID-19 vaccination series without presenting any safety or effectiveness concerns. The products are legally distinct with certain differences that do not impact safety or effectiveness.
The employer needs to be notified that the Comirnaty jab, that is the only FDA approved jab, is not even available in the US and there is no timetable available for when it will be. Although the FDA has stated that the BioNTech jab is interchangeable with Comirnaty, they are treated as two separate entities and are not the same jab. The BioNTech jab is still under EUA and is classified as experimental. There are NO FDA approved vaxxines available in the US - PERIOD!
Therefore, all the current vaxxines available in the US are still under EUA only and cannot be mandated. In addition, the liability waiver for those jabs is still in effect and no data is available as to the complete list of ingredients they contain and must still be classified as part of a clinical trial. Complete informed consent is impossible.
Comirnaty has the same formulation as the FDA-authorized Pfizer-BioNTech COVID-19 vaccine and can be used interchangeably to provide the COVID-19 vaccination series without presenting any safety or effectiveness concerns. The products are legally distinct with certain differences that do not impact safety or effectiveness.
The employer needs to be notified that the Comirnaty jab, that is the only FDA approved jab, is not even available in the US and there is no timetable available for when it will be. Although the FDA has stated that the BioNTech jab is interchangeable with Comirnaty, they are treated as two separate entities and are not the same jab. The BioNTech jab is still under EUA and is classified as experimental. There are NO FDA approved vaxxines available in the US - PERIOD!
Therefore, all the current vaxxines available in the US are still under EUA only and cannot be mandated.
Comirnaty has the same formulation as the FDA-authorized Pfizer-BioNTech COVID-19 vaccine and can be used interchangeably to provide the COVID-19 vaccination series without presenting any safety or effectiveness concerns. The products are legally distinct with certain differences that do not impact safety or effectiveness.
The employer needs to be notified that the Comirnaty jab, that is the only FDA approved jab, is not even available in the US and there is no timetable available for when it will be. Although the FDA has stated that the BioNTech jab is interchangeable with Comirnaty, they are treated as two separate entities and are not the same jab. The BioNTech jab is still under EUA and is classified as experimental. There are NO FDA approved vaxxines available in the US - PERIOD!
Therefore, all the current vaxxines available in the US are still under EUA only and cannot be mandated.
Comirnaty has the same formulation as the FDA-authorized Pfizer-BioNTech COVID-19 vaccine and can be used interchangeably to provide the COVID-19 vaccination series without presenting any safety or effectiveness concerns. The products are legally distinct with certain differences that do not impact safety or effectiveness.